DanielAvramOrringerMDFAANS
Neurosurgery • New York, NYBrain & Spinal Tumor
Neurosurgeon, NYU Neurosurgery
Dr. Orringer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 First Ave
Suite 8S, SKI
New York, NY 10016Phone+1 212-263-0909
Education & Training
University of MichiganResidency, Neurological Surgery, 2004 - 2011- University of Michigan Health SystemInternship, Transitional Year, 2004 - 2005
Ohio State University College of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2019 - 2026
MI State Medical License 2004 - 2022
MA State Medical License 2011 - 2012- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma Start of enrollment: 2020 Oct 28
Publications & Presentations
PubMed
- Medical large language models are vulnerable to data-poisoning attacks.Daniel Alexander Alber, Zihao Yang, Anton Alyakin, Eunice Yang, Sumedha Rai
Nature Medicine. 2025-01-08 - Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update.Nataniel Mandelberg, Tiffany R Hodges, Tony J C Wang, Tresa McGranahan, Jeffrey J Olson
Journal of Neuro-Oncology. 2025-01-02 - Intraoperative margin assessment with near real time pathology during partial gland ablation of prostate cancer: A feasibility study.Miles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu, Christian Freudiger, Derek Jones
Urologic Oncology. 2025-01-01
Authored Content
- Recently Viewed (1) Article Information Headings References TrendMD Metrics PubMed Google ScholarNovember 2018
Press Mentions
University of Michigan Developed 'Unprecedented' AI Tool to Improve Brain Tumor SurgeryDecember 10th, 2024- AI Testing of Brain Tumors Can Detect Genetic Cancer Markers in Less Than 90 Seconds, Study FindsApril 3rd, 2023
- DeepGlioma AI Classifies Brain Tumors Within 90 Seconds—and with 93% Accuracy, Study FindsMarch 27th, 2023
- Join now to see all
Grant Support
- Nanoparticle-Enabled Brain Tumor SurgeryNational Cancer Institute2007–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
